Full-Time

Quality Systems and Compliance - Digital Lead

Quality Systems and Compliance

Posted on 9/23/2025

Kyowa Kirin

Kyowa Kirin

1,001-5,000 employees

Global specialty pharma leveraging fermentation and antibodies

Compensation Overview

$137k - $178.9k/yr

Sanford, NC, USA

In Person

Requires up to 10% domestic and limited international travel.

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Bachelor’s degree in Computer Science or a related scientific or technical discipline (required).
  • Minimum of 8 years of experience in a GxP-regulated environment, with a focus on Quality Assurance for computerized systems and digital platforms.
  • Demonstrated experience in computerized system validation (CSV), including reviewing system requirements, protocols, risk assessments, and technical documentation.
  • Experience in data governance, including master data management, metadata standards, and data lifecycle controls.
  • Proven ability to collaborate cross-functionally with Automation, IT, Engineering, and Manufacturing teams to ensure systems are implemented and maintained in compliance with 21 CFR Part 11, EU Annex 11, and ALCOA++ principles.
  • Strong understanding of data integrity requirements, electronic records/electronic signatures (ERES), and global regulatory expectations for GxP systems.
  • Prior involvement in regulatory inspections or audits, including preparation, participation, and response development.
  • Excellent communication and documentation skills, with the ability to author SOPs, training materials, and technical reports.
  • Must be able to work in an office and regulated manufacturing environment, including construction/start-up phases, with appropriate PPE. Reasonable accommodation will be provided as required by law.
  • This position is based on-site in Sanford, NC.
  • Requires up to 10% domestic and limited international travel.
  • This position reports to the Sr. Manager, Quality Systems & Compliance
  • Bachelor’s degree... (text already included above)
Responsibilities
  • The Quality Systems & Compliance, Digital Lead plays a critical role in ensuring adherence to global regulatory requirements—including 21 CFR Part 11, EU Annex 11, and data governance and integrity standards—during the design, implementation, and integration of GxP computerized and automated systems at Kyowa Kirin’s new North American monoclonal antibody drug substance manufacturing facility in Sanford, NC. Initially operating in a greenfield environment, this role evolves into a key technical contributor within the Quality Systems & Compliance team, driving GMP readiness, technical transfer, and facility licensure activities for clinical and commercial manufacturing.
  • As the technical quality lead, you will influence compliance strategies across the lifecycle of cGxP computerized systems, partnering with designated system owners and cross-functional teams to ensure validation, inspection readiness, and regulatory alignment.
  • You will lead site-wide efforts to prepare for audits and inspections, manage regulatory response activities, and serve as a subject matter expert in automation, digital platforms, and data integrity.
  • Additionally, you will own training and capability-building initiatives for all site colleagues, fostering a culture of quality, collaboration, and operational excellence.
  • As an individual contributor, you will take a compassionate and people-focused approach to your work. You will proactively collaborate with others to create a supportive and inclusive environment, always acting in line with the organization’s values. By using strong interpersonal skills, you will work effectively with diverse viewpoints, manage relationships thoughtfully, and make decisions that meet both individual and team needs. You will be accountable for delivering results, adapting to challenges, and helping achieve business goals. Additionally, you will take ownership of your tasks, act with initiative, and continuously seek opportunities to learn and grow. You will handle change with resilience and clarity, staying flexible in a fast-paced environment while keeping the needs of patients at the center of your efforts.
  • This position reports to the Sr. Manager, Quality Systems & Compliance
  • Drive the implementation and validation of automation and technology systems—including ERP, MES, LIMS, and site infrastructure—by aligning with global, regional, and site teams to meet internal and external regulatory requirements (e.g., FDA, EMA, ICH), uphold patient-centric principles, and maintain continuous inspection readiness across all GxP areas.
  • Lead cross-functional collaboration across all site functions to design and execute automation strategies that accelerate digital transformation and enhance operational efficiency in manufacturing, laboratory, engineering, warehouse, and quality operations.
  • Designs and optimizes automated workflows to achieve business objectives, ensure global regulatory compliance, and optimize performance across GxP operations.
  • Establish and enforce the site’s data governance framework by defining master data management protocols, metadata standards, and data lifecycle controls to ensure consistent, compliant, and high-quality data across all digital platforms.
  • Monitor and communicate progress on Quality Systems goals by delivering performance reports and presenting actionable insights to the Site Leadership Team and stakeholders, enabling informed decision-making and continuous improvement.
  • Shape Quality IT strategies and system selection processes during early-stage site activities by defining user requirements, evaluating system options, and influencing procurement decisions to ensure electronic systems meet compliance and operational needs.
  • Ensure site-wide compliance with global data integrity standards (e.g., ALCOA++, 21 CFR Part 11) by leading the design, implementation, and integration of GxP electronic systems in coordination with Global and Regional teams, aligned with approved plans and budgets.
  • Apply robust risk management methodologies to ensure systems comply with global, regional, and site procedures by documenting risk-based decisions with sound rationales, factual evidence, and relevant data to promote transparency, consistency, and audit readiness.
  • Partner with all site functions to achieve production targets compliantly across Manufacturing, Warehouse, Engineering, and Laboratory areas by aligning quality processes, resolving operational challenges, and reinforcing adherence to regulatory standards.
  • Influence the QA qualification strategy for computerized systems, infrastructure, and automation technologies by guiding cross-functional teams and ensuring systems are validated and ready for commissioning and operational launch in alignment with regulatory and business objectives, while partnering with designated CSV owners to ensure compliance.
  • Serve as a core member of the site-based inspection management team by leading timely, compliant responses to regulatory inquiries, coordinating targeted GxP refresher trainings, and conducting regular walkthroughs of GxP areas to proactively identify risks and ensure continuous inspection readiness.
  • Deliver site-wide onboarding, training, and mentoring for employees and contractors in accordance with approved staffing plans by providing role-specific guidance, facilitating knowledge transfer, and ensuring readiness to perform in compliance with operational and regulatory standards.
  • Define and track key performance indicators in collaboration with Global and Regional teams to assess site performance against QMS requirements and lead periodic site management reviews with the Site Leadership Team to drive continuous improvement and ensure alignment with quality objectives.
  • Lead inspection readiness activities across all GxP areas by conducting GEMBA walks and readiness walkthroughs, engaging cross-functional teams to proactively identify and resolve gaps, and driving timely completion of action plans from audits, inspections, or risk mitigation efforts to ensure sustained compliance and operational excellence.
Desired Qualifications
  • Master’s degree in Computer Science or a related scientific or technical discipline (preferred).
  • Experience supporting greenfield or facility start-up projects—including GMP readiness, technical transfer, and inspection preparation—is highly desirable.

Kyowa Kirin is a global specialty pharmaceutical company that develops medicines using fermentation and antibody technologies. Its products target areas like nephrology, oncology, and immunology, with therapies built from biologics and other drug modalities. The company emerged from a merger between Kyowa Hakko Kogyo and Kirin Pharma, combining Kyowa’s fermentation and microbiology expertise with Kirin’s pharma resources to create a worldwide focus on specialty drugs. Unlike broader drug companies, Kyowa Kirin concentrates on a defined set of indications and runs a research-and-development-led business that aims to deliver innovative treatments for patients in need.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1885

Simplify Jobs

Simplify's Take

What believers are saying

  • Libmeldy commercialization in MLD expands rare disease revenue streams globally.
  • Orchard pipeline programs in MPS, FTD, Crohn's disease address high unmet needs.
  • North Carolina manufacturing capacity supports cell and gene therapy market growth.

What critics are saying

  • Libmeldy reimbursement denial in UK, Germany, US collapses primary revenue driver.
  • Orchard pipeline failures in Phase 2/3 trials eliminate $478M acquisition rationale.
  • Gene therapy manufacturing delays at Sanford facility constrain supply and revenue ramp.

What makes Kyowa Kirin unique

  • 75+ years fermentation expertise underpins proprietary antibody and gene therapy platforms.
  • Orchard Therapeutics acquisition adds Libmeldy gene therapy for rare genetic diseases.
  • $530M Sanford biologics facility enables scaled manufacturing of advanced cell therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

Paid Vacation

Paid Sick Leave

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Hybrid Work Options

Pet Insurance

Tuition Assistance

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-1%
Benzinga
Dec 15th, 2025
Link Cell Therapies raises $92M to advance CAR-T cancer treatments for solid and liquid tumors

Link Cell Therapies has emerged from stealth with $60 million in Series A funding led by Johnson & Johnson Innovation – JJDC, bringing total capital raised to $92 million. The South San Francisco–based oncology company is developing CAR-T therapies for solid and liquid tumours using proprietary logic-gating technology. The platform enables safe targeting of multiple antigens co-expressed on cancer cells whilst sparing healthy tissue. Co-founded by Dr Robbie Majzner and Dr Crystal Mackall at Stanford University in 2022, Link's lead programme, LNK001 for renal cell carcinoma, is on track for an IND application and Phase I trial in 2026. The Series A round included participation from founding investors Samsara BioCapital and Sheatree Capital, alongside new backers Bristol Myers Squibb, Kyowa Kirin and Wing Venture Capital.

FinSMEs
Mar 4th, 2025
Garuda Therapeutics Closes $50M Series A-1 Financing

Garuda Therapeutics, a Cambridge, MA-based hematopoietic stem cell (HSC) therapies company, raised $50M in Series A-1 funding

Cimeio Therapeutics
Dec 10th, 2024
Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies

The partnership combines Cimeio's proprietary Shielded Cell and Immunotherapy (SCIP) platform with Kyowa Kirin's expertise in cellular therapies and underscores both companies' commitment to using emerging cell and gene therapy technologies to develop new ways to treat patients.

Business North Carolina
Nov 27th, 2024
Op/ed: Biotech's role in North Carolina's job-creation success

Kyowa Kirin, a Japanese global specialty pharmaceutical company, plans to invest more than $200 million in Sanford to build its first pharmaceutical manufacturing complex in North America, adding more than 100 new jobs.

World Pharmaceutical Frontiers
Jun 11th, 2024
Kyowa Kirin to establish new $530m biologics manufacturing plant in US

Japan-based Kyowa Kirin has unveiled its plans to invest $530m to build a new advanced biologics manufacturing facility in Sanford in the American state of North Carolina.

INACTIVE